Eimeric Reig-Plessis

Eimeric’s representative experience includes the following:

• Orally argued and briefed § 101 motion and obtained judgment on the pleadings three days after argument—invalidating patents that two other defendants represented by separate firms were unable to defeat on the same grounds.
• Second-chaired a seven-day trial and examined two key experts in a Hatch-Waxman case involving a drug with annual sales of approximately $1 billion—obtained invalidation of six patents as obvious and affirmance on appeal.
• Briefed § 101 motion to dismiss and obtained summary invalidation on the papers of six asserted patents on wireless audio devices that were previously asserted in a multi-million dollar action against another defendant.
• In a plaintiff-side case for a consumer products patentee, orally argued Markman hearing and won on all disputed terms—defeating indefiniteness defenses and noninfringement constructions—and briefed successful preliminary responses to IPR petitions, securing denials of institution on the merits for all asserted patents. 
• Briefed § 101 motion for judgment on the pleadings and obtained invalidation on the papers of a multimedia communication patent that had survived IPR brought by a prior firm where the patentee sought damages exceeding $100 million.
• Orally argued and briefed appeal before the Seventh Circuit in a pro bono action for denial of medical care under the Eighth Amendment—obtained reversal of summary judgment on a novel issue of administrative exhaustion.
• Briefed successful IPR patent challenges on behalf of five generic drug makers before the PTAB and Federal Circuit—obtained cancelation of all claims (more than 50) as obvious and summary affirmance on appeal.
• Briefed first-ever antitrust challenge to a “sham” FDA citizen petition before the Federal Circuit in a counterclaim to Hatch-Waxman litigation—obtained reversal of adverse judgment on appeal and denial of summary judgment on remand.